Looking to bag the record high ResMed dividend? You better hurry!

Unlike the majority of ASX 200 income stocks, ResMed pays dividends every quarter.

| More on:

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the 'five best ASX stocks' for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now...

See The 5 Stocks *Returns as of 30 April 2025

A person is weighed down by a huge stack of coins, they have received a big dividend payout.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Time is running short for passive income investors wanting to bank the all-time high ResMed Inc (ASX: RMD) dividend.

Unlike the majority of ASX income stocks, which pay dividends twice a year, the S&P/ASX 200 Index (ASX: XJO) sleep disorder treatment company pays out quarterly dividends.

Here's what's happening with the upcoming dividend.

ResMed dividend soars alongside surge in income

The record ResMed dividend was declared when the healthcare company reported its December quarterly results on 31 January.

For the three months to 31 December, the company reported revenue of US$1.3 billion. That was up 10% year over year, driven by growing demand for its sleep devices and masks and growth in its Residential Care Software business.

ResMed also achieved a 52% increase in income from operation to US$417.2 million. Non-GAAP net income of US$358.3 million was up 29% from the prior corresponding quarter.

During the quarter, ResMed paid $78 million in dividends to its shareholders.

As for the upcoming ResMed dividend in question, the board declared an unfranked quarterly cash dividend of 5.3 US cents per share. In Aussie currency, that equates to around 8.5 cents and represents an increase of around 10% over the dividend paid for the same quarter last year.

ASX investors will receive their ResMed dividend on 13 February, the record date.

If you're hoping to grab that passive income payout, you'll need to own shares at market close on Tuesday, 11 February. ResMed shares trade ex-dividend on 12 February.

What did management say?

Commenting on the company's strong quarterly results that enabled a record ResMed dividend payout, CEO Mick Farrell said on the day:

Our second quarter fiscal year 2025 top-line growth, margin expansion, and double-digit EPS growth were the result of increased demand for our sleep health and breathing health products and digital health solutions that people love, as well as our laser-focus on operational excellence.

We delivered 10% year-over-year revenue growth, 230 bps improvement in gross margin, and $309 million of operating cash flow.

Atop the ResMed dividend, is the stock a good buy?

Buying a stock simply for its passive income can backfire if the company's share price goes backwards over the year.

So, atop the pending ResMed dividend, is the ASX 200 healthcare stock a good buy?

Taking a look in the rearview, the ResMed share price has gained an impressive 32.0% over the past 12 months.

As for what lies ahead, Goldman Sachs has a bullish outlook for the company.

Following ResMed's quarterly update, the broker noted that "the result reinforced the various growth levers which RMD has greater control over".

Goldman Sachs reiterated its buy rating on ResMed shares with a $49.00 price target. That represents a potential upside of almost 27% from the current $38.64 a share.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Dividend Investing

Friend enjoying a meal at a restaurant, symbolising passive income.
Dividend Investing

3 top ASX dividend stocks paying market-beating passive income

These top ASX passive income stocks are paying dividend yields of 8% to 10%.

Read more »

Joyful woman at a beach on the Gold Coast with her arms spread out.
Dividend Investing

10 high-conviction ASX dividend shares to buy for passive income today

With interest rates falling, it might be a good time to buy dividend stocks.

Read more »

A couple makes silly chip moustache faces and take a selfie on their phone.
Dividend Investing

Worried about falling interest rates? Here are 2 ASX 200 income shares to replace a term deposit today

Dividend shares are looking better and better in 2025.

Read more »

Man smiling at a laptop because of a rising share price.
Dividend Investing

Guess which high-yielding ASX All Ords dividend stock Macquarie expects to surge 34% in a year

Looking for market-beating passive income and share price gains? Check out this ASX All Ords stock!

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Dividend Investing

Buy BHP, Telstra, and this ASX dividend share

Brokers are tipping these shares as buys for income investors. But why?

Read more »

The letters ETF sit in orange on top of a chart with a magnifying glass held over the top of it
Dividend Investing

Boosting passive income: With a 7.6% yield, is the YMAX ETF a good option?

Is this ETF's yield too good to be true?

Read more »

A man in a business shirt and tie takes a wide leap over a large steel trap with jagged teeth.
Bank Shares

5.75% yield: Are ANZ shares a dividend trap?

ANZ's dividend currently beats out its own term deposits.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Dividend Investing

Here are 3 buy-rated ASX dividend stocks to beat falling interest rates

Brokers are recommending these stocks to clients.

Read more »